LMR Partners’s Bristol-Myers Squibb BMY Stock Holding History

LMR Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.6M	Buy	1,114,300 +614,900	+123%	+$35.8M	0.15%	66
2025 Q4	$26.9M	Sell	499,400 -113,400	-19%	-$5.46M	0.05%	163
2025 Q3	$27.6M	Buy	612,800 +350,400	+134%	+$16.4M	0.12%	139
2025 Q2	$12.1M	Buy	262,400 +142,400	+119%	+$6.99M	0.09%	236
2025 Q1	$7.32M	Buy	+120,000	New	+$6.99M	0.07%	314
2024 Q4	–	Sell	-50,000	Closed	-$2.59M	–	1232
2024 Q3	$2.59M	Buy	+50,000	New	+$2.35M	0.02%	534
2024 Q2	–	Sell	-30,000	Closed	-$1.63M	–	1116
2024 Q1	$1.63M	Buy	+30,000	New	+$1.53M	0.02%	593

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LMR Partners's BMY Position: Q1 2026 in Review

LMR Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.24% in Q1 2026, selling an estimated $700 and leaving 5,001 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

LMR Partners first reported a position in BMY in Q4 2014 and has held it in 21 quarters since. The position peaked at $13.5M in Q3 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

LMR Partners held 5,001 shares of Bristol-Myers Squibb worth $303K as of Q1 2026.
LMR Partners sold 12 Bristol-Myers Squibb shares in Q1 2026, an estimated $700.
Bristol-Myers Squibb made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1141 holding.
LMR Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 21 quarters since.
LMR Partners's Bristol-Myers Squibb position peaked at $13.5M in Q3 2024.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.